RAFAEL HOLDINGS, INC. Revenue from Related Parties
RAFAEL HOLDINGS, INC. (RFL) reported Revenue from Related Parties of $27.00 thousand for the 3-month period ending 2023-01-31, per its 10-Q filed 2023-03-14.
Discontinued › Income Statement › Other Income
us-gaap:RevenueFromRelatedParties · last filed 2023-03-14
- RAFAEL HOLDINGS, INC. revenue from related parties for the quarter ending 2023-01-31 was $27.00K, a 6.90% decline year-over-year.
- RAFAEL HOLDINGS, INC. revenue from related parties for the quarter ending 2022-10-31 was $27.00K, a 0.00% change year-over-year.
- RAFAEL HOLDINGS, INC. revenue from related parties for the quarter ending 2022-07-31 was -$1.64M.
- RAFAEL HOLDINGS, INC. revenue from related parties for the quarter ending 2022-04-30 was $524.00K, a 0.19% increase year-over-year.
- RAFAEL HOLDINGS, INC. revenue from related parties for fiscal 2022 was $111.00K, a 2.78% increase from fiscal 2021.
- RAFAEL HOLDINGS, INC. revenue from related parties for fiscal 2021 was $108.00K, a 94.81% decline from fiscal 2020.
- RAFAEL HOLDINGS, INC. revenue from related parties for fiscal 2020 was $2.08M, a 2.02% decline from fiscal 2019.
- RAFAEL HOLDINGS, INC. revenue from related parties for fiscal 2019 was $2.13M, a 4.41% decline from fiscal 2018.
| Period end | Revenue from Related Parties 3 month | Revenue from Related Parties 3 month as first filed | Revenue from Related Parties 6 month | Revenue from Related Parties 6 month as first filed | Revenue from Related Parties 9 month | Revenue from Related Parties 12 month | Revenue from Related Parties 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-01-31 | $27.00K 10-Q · filed 2023-03-14 | $54.00K 10-Q · filed 2023-03-14 | -$1.58M derived: sum of 3 quarters · filed 2023-03-14 | -$1.06M derived: sum of 4 quarters · filed 2023-03-14 | |||
| 2022-10-31 | $27.00K 10-Q · filed 2022-12-13 | -$1.61M derived: sum of 2 quarters · filed 2022-12-13 | -$1.09M derived: sum of 3 quarters · filed 2022-12-13 | -$1.06M derived: sum of 4 quarters · filed 2023-03-14 | |||
| 2022-07-31 | -$1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | -$1.11M derived: sum of 2 quarters · filed 2022-10-31 | -$1.08M derived: sum of 3 quarters · filed 2023-03-14 | $111.00K 10-K · filed 2022-10-31 | |||
| 2022-04-30 | $524.00K 10-Q · filed 2022-06-14 | $553.00K derived: sum of 2 quarters · filed 2023-03-14 | $1.75M 10-Q · filed 2022-06-14 | -$882.00K derived: sum of 4 quarters · filed 2023-03-14 | |||
| 2022-01-31 | $29.00K 10-Q · filed 2023-03-14 | $705.00K 10-Q · filed 2022-03-17 | $56.00K 10-Q · filed 2023-03-14 | $1.23M 10-Q · filed 2022-03-17 | -$1.41M derived: sum of 3 quarters · filed 2023-03-14 | -$883.00K derived: sum of 4 quarters · filed 2023-03-14 | |
| 2021-10-31 | $27.00K 10-Q · filed 2022-12-13 | $520.00K 10-Q · filed 2021-12-15 | -$1.44M derived: sum of 2 quarters · filed 2022-12-13 | -$912.00K derived: sum of 3 quarters · filed 2022-12-13 | -$385.00K derived: sum of 4 quarters · filed 2022-12-13 | ||
| 2021-07-31 | -$1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | -$939.00K derived: sum of 2 quarters · filed 2022-10-31 | -$412.00K derived: sum of 3 quarters · filed 2022-10-31 | $108.00K 10-K · filed 2022-10-31 | $2.10M 10-K · filed 2021-10-18 | ||
| 2021-04-30 | $523.00K 10-Q · filed 2022-06-14 | $1.05M derived: sum of 2 quarters · filed 2022-06-14 | $1.57M 10-Q · filed 2022-06-14 | $2.08M derived: sum of 4 quarters · filed 2022-06-14 | |||
| 2021-01-31 | $527.00K 10-Q · filed 2022-03-17 | $1.05M 10-Q · filed 2022-03-17 | $1.56M derived: sum of 3 quarters · filed 2022-03-17 | $2.08M derived: sum of 4 quarters · filed 2022-03-17 | |||
| 2020-10-31 | $520.00K 10-Q/A · filed 2022-02-28 | $1.03M derived: sum of 2 quarters · filed 2022-02-28 | $1.55M derived: sum of 3 quarters · filed 2022-02-28 | $2.08M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-07-31 | $512.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | $1.03M derived: sum of 2 quarters · filed 2021-10-18 | $1.56M derived: sum of 3 quarters · filed 2021-10-18 | $2.08M 10-K · filed 2021-10-18 | |||
| 2020-04-30 | $523.00K 10-Q · filed 2021-06-14 | $1.05M derived: sum of 2 quarters · filed 2021-06-14 | $1.57M 10-Q · filed 2021-06-14 | $2.13M derived: sum of 4 quarters · filed 2021-06-14 | |||
| 2020-01-31 | $527.00K 10-Q · filed 2021-03-17 | $1.05M 10-Q · filed 2021-03-17 | $1.61M derived: sum of 3 quarters · filed 2021-03-17 | $2.13M derived: sum of 4 quarters · filed 2021-03-17 | |||
| 2019-10-31 | $520.00K 10-Q · filed 2020-12-15 | $1.08M derived: sum of 2 quarters · filed 2020-12-15 | $1.60M derived: sum of 3 quarters · filed 2020-12-15 | $2.12M derived: sum of 4 quarters · filed 2020-12-15 | |||
| 2019-07-31 | $561.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-29 | $1.08M derived: sum of 2 quarters · filed 2020-10-29 | $1.60M derived: sum of 3 quarters · filed 2020-10-29 | $2.13M 10-K · filed 2020-10-29 | |||
| 2019-04-30 | $521.00K 10-Q · filed 2020-06-09 | $1.04M derived: sum of 2 quarters · filed 2020-06-09 | $1.56M 10-Q · filed 2020-06-09 | $2.35M derived: sum of 4 quarters · filed 2020-06-09 | |||
| 2019-01-31 | $522.00K 10-Q · filed 2020-03-05 | $1.04M 10-Q · filed 2020-03-05 | $1.82M derived: sum of 3 quarters · filed 2020-03-05 | $2.27M derived: sum of 4 quarters · filed 2020-03-05 | |||
| 2018-10-31 | $521.00K 10-Q · filed 2019-12-09 | $1.30M derived: sum of 2 quarters · filed 2019-12-09 | $1.75M derived: sum of 3 quarters · filed 2019-12-09 | $2.24M derived: sum of 4 quarters · filed 2019-12-09 | |||
| 2018-07-31 | $781.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04 | $1.23M derived: sum of 2 quarters · filed 2019-10-04 | $1.72M derived: sum of 3 quarters · filed 2019-10-04 | $2.22M 10-K · filed 2019-10-04 | |||
| 2018-04-30 | $447.00K 10-Q · filed 2019-06-05 | $936.00K derived: sum of 2 quarters · filed 2019-06-05 | $1.44M 10-Q · filed 2019-06-05 | $2.47M derived: sum of 4 quarters · filed 2019-06-05 | |||
| 2018-01-31 | $489.00K 10-Q · filed 2019-03-12 | $994.00K 10-Q · filed 2019-03-12 | $2.02M derived: sum of 3 quarters · filed 2019-03-12 | $2.87M derived: sum of 4 quarters · filed 2019-03-12 | |||
| 2017-10-31 | $505.00K 10-Q · filed 2018-12-10 | $1.53M derived: sum of 2 quarters · filed 2018-12-10 | $2.38M derived: sum of 3 quarters · filed 2018-12-10 | $3.15M derived: sum of 4 quarters · filed 2018-12-10 | |||
| 2017-07-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15 | $1.88M derived: sum of 2 quarters · filed 2018-10-15 | $2.65M derived: sum of 3 quarters · filed 2018-10-15 | $3.71M 10-K · filed 2018-10-15 | |||
| 2017-04-30 | $854.00K 10-Q · filed 2018-06-11 | $1.62M derived: sum of 2 quarters · filed 2018-06-11 | $2.68M 10-Q · filed 2018-06-11 | ||||
| 2017-01-31 | $770.00K 10-Q · filed 2018-03-12 | $1.68M 10-Q · filed 2018-03-12 | |||||
| 2016-07-31 | $3.73M 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |